BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of entries related to H23 cell line is 28
| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CD24 | 1645 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H23 | Cisplatin | SFA followed by IF staining and Western Blotting | NA | 0.52 | 0.456 | 26872057 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H23 | Cisplatin | SFA followed by IF staining and Western Blotting | NA | 0.52 | 1 | 26872057 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H23 | NA | FACs followed by IHC staining and SFA | NA | 0.52 | 1 | 21124918 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H23 | NA | SFA followed by FACs | NA | 0.52 | 1 | 29190547 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H23 | Cisplatin | SFA followed by IF staining and Western Blotting | NA | 0.52 | 0.5461 | 26872057 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H23 | NA | qRT-PCR and Western Blotting | NA | 0.52 | 0.5461 | 34063628 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H23 | NA | SFA and qRT-PCR | NA | 0.52 | 0.5461 | 29980786 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H23 | Cisplatin | SFA followed by IF staining and Western Blotting | NA | 0.52 | 0.6448 | 26872057 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H23 | NA | qRT-PCR and Western Blotting | NA | 0.52 | 0.6448 | 34063628 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H23 | NA | FACs followed by IF staining | NA | 0.52 | 0.6448 | 21124918 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H23 | NA | SFA followed by Western Blotting | NA | 0.52 | 0.6448 | 32509180 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H23 | NA | SFA and qRT-PCR | NA | 0.52 | 0.6448 | 29980786 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H23 | Cisplatin | SFA followed by IF staining and Western Blotting | NA | 0.52 | 0.7582 | 26872057 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H23 | NA | FACs | NA | 0.52 | 0.7582 | 27920206 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H23 | NA | FACs and SFA | NA | 0.52 | 0.7582 | 34063628 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H23 | NA | SFA followed by FACs | NA | 0.52 | 0.7582 | 34349823 |
| PAX6 | 8620 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H23 | NA | SFA followed by qRT-PCR and Western Blotting and Tumorigenicity assay | NA | 0.48 | 0.0021 | 29980786 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H23 | NA | qRT-PCR and Western Blotting | NA | 0.48 | 0.5695 | 34063628 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H23 | NA | SFA and qRT-PCR | NA | 0.48 | 0.5695 | 29980786 |
| IL6 | 6018 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H23 | 5-fluorouracil | FACs followed by qRT-PCR | NA | 0.32 | 0.0191 | 22416214 |
| IL6 | 6018 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H23 | Methotrexate | FACs followed by qRT-PCR | NA | 0.32 | 0.0191 | 22416214 |
| ABCG2 | 74 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H23 | Cisplatin | SFA followed by Western Blotting | NA | 0.28 | 0.1739 | 26872057 |
| ABCG2 | 74 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H23 | NA | SP assay followed by invasion assay and RT-PCR | NA | 0.28 | 0.1739 | 17510412 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H23 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.684 | 32509180 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H23 | Cisplatin | SFA followed by FACs | NA | 0.28 | 0.684 | 26872057 |
| GLI1 | 4317 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H23 | NA | Western Blotting followed by CFA and SFA | NA | 0.28 | 0.0308 | 32509180 |
| BMI1 | 1066 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H23 | NA | FACs | NA | 0.12 | 0.1135 | 21124918 |
| DRD2 | 3023 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H23 | NA | FACs | NA | 0.12 | 0.0011 | 27920206 |